ARCHIVES

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

This article is from The Cancer Letter archive.

Vol. 17 No. 09 | March 1, 1991

Download PDF Visit The Full Archive

Related Articles

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Atlas Showing County Cancer Rates Available

July 18, 1975

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007